Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.

New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu

Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.

Reconstructing a lifetime of flu infections to understand long-term trends

Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.

£5.5m funding boost for health protection research on emerging and zoonotic infections

University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.

Moh Family Foundation visit highlights vital support for pandemic preparedness research

The Pandemic Sciences Institute welcomed the Moh Family Foundation to Oxford to share latest research updates and celebrate the Foundation’s generous support.

Large-scale study on Long Covid highlights urgent, global need for investment

A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.

Study suggests possible new transmission route for highly pathogenic avian influenza

Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.

Study explores aerosol immunisation as path to broadly protective influenza vaccine

Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.

New multidisciplinary programme to develop digital pandemic tools

The Oxford Martin Programme on Digital Pandemic Preparedness will be co-led by researchers affiliated with the Pandemic Sciences Institute.

PSI seminar series launches with talk on pandemic control measures

Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.

Oxford Vaccine Group announces return of science and healthcare podcast

A brand-new season of The Oxford Colloquy – a podcast series of conversations with leading experts in science and healthcare – is launched this week by Oxford Vaccine Group.

PSI collaborates with Oxford’s History of Science Museum on new exhibition

The latest exhibition "A Healthy Future for All?" explores the science driving advancements in healthcare

International Pandemic Sciences Conference 2024 concludes with record-breaking attendance and global impact

The International Pandemic Sciences Conference 2024, held on 1 and 2 July in Oxford and online, has concluded with remarkable success, drawing over 700 delegates from more than 60 countries.

PSI Director comments on first UK Covid-19 Inquiry report

Professor Sir Peter Horby responds to the UK Covid-19 Inquiry's Module 1 report published today, which focuses on the UK's pandemic resilience and preparedness.

Oxford scientists launch first-in-human vaccine trial for deadly Marburg virus

Launch of UK trial is major milestone in developing a vaccine against Marburg virus – a highly virulent disease that is fatal in up to 88% of cases.

COVID-19 phone app shown to provide real-time information on the spread of infectious diseases

Researchers analysing data from mobile phone apps used during the COVID-19 pandemic found that digital contact tracing can help public health bodies to better monitor and analyse evolving epidemics.

Last chance to register for the International Pandemic Sciences Conference 2024

Mark your calendars for the International Pandemic Sciences Conference 2024, coming to Oxford and streaming online on 1 and 2 July 2024.

Pandemic computer simulations to guide future vaccine trials

PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.

Professor Teresa Lambe elected to Fellowship of Academy of Medical Sciences

Professor Teresa Lambe OBE, Calleva Head of Immunology at the Oxford Vaccine Group, and Principal Investigator at the Pandemic Sciences Institute, has been elected a Fellow of the Academy of Medical Sciences, one of the most prestigious awards in the field.

PSI Director Professor Sir Peter Horby elected Fellow of Royal Society

Professor Sir Peter Horby has been elected as a Fellow of the Royal Society, joining a cohort of the world’s most eminent scientists, engineers and technologists who have made substantial contributions to the advancement of science.

Load More